- Tissue microarray analysis reveals site-specific prevalence of oncogene amplifications in head and neck squamous cell carcinoma. Freier, K., Joos, S., Flechtenmacher, C., Devens, F., Benner, A., Bosch, F.X., Lichter, P., Hofele, C. Cancer Res. (2003)
- Detection of Her2/neu, c-MYC and ZNF217 gene amplification during breast cancer progression using fluorescence in situ hybridization. Shimada, M., Imura, J., Kozaki, T., Fujimori, T., Asakawa, S., Shimizu, N., Kawaguchi, R. Oncol. Rep. (2005)
- CAS (cellular apoptosis susceptibility) gene expression in ovarian carcinoma: Correlation with 20q13.2 copy number and cyclin D1, p53, and Rb protein expression. Peiró, G., Diebold, J., Löhrs, U. Am. J. Clin. Pathol. (2002)
- Measurement of DNA copy number at microsatellite loci using quantitative PCR analysis. Ginzinger, D.G., Godfrey, T.E., Nigro, J., Moore, D.H., Suzuki, S., Pallavicini, M.G., Gray, J.W., Jensen, R.H. Cancer Res. (2000)
- The candidate oncogene ZNF217 is frequently amplified in colon cancer. Rooney, P.H., Boonsong, A., McFadyen, M.C., McLeod, H.L., Cassidy, J., Curran, S., Murray, G.I. J. Pathol. (2004)
- Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Albertson, D.G., Ylstra, B., Segraves, R., Collins, C., Dairkee, S.H., Kowbel, D., Kuo, W.L., Gray, J.W., Pinkel, D. Nat. Genet. (2000)
- Positional cloning of ZNF217 and NABC1: genes amplified at 20q13.2 and overexpressed in breast carcinoma. Collins, C., Rommens, J.M., Kowbel, D., Godfrey, T., Tanner, M., Hwang, S.I., Polikoff, D., Nonet, G., Cochran, J., Myambo, K., Jay, K.E., Froula, J., Cloutier, T., Kuo, W.L., Yaswen, P., Dairkee, S., Giovanola, J., Hutchinson, G.B., Isola, J., Kallioniemi, O.P., Palazzolo, M., Martin, C., Ericsson, C., Pinkel, D., Albertson, D., Li, W.B., Gray, J.W. Proc. Natl. Acad. Sci. U.S.A. (1998)
- Specific Recognition of ZNF217 and Other Zinc Finger Proteins at a Surface Groove of C-Terminal Binding Proteins. Quinlan, K.G., Nardini, M., Verger, A., Francescato, P., Yaswen, P., Corda, D., Bolognesi, M., Crossley, M. Mol. Cell. Biol. (2006)
- The ZNF217 oncogene is a candidate organizer of repressive histone modifiers. Banck, M.S., Li, S., Nishio, H., Wang, C., Beutler, A.S., Walsh, M.J. Epigenetics. (2009)
- Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark. Ruthenburg, A.J., Allis, C.D., Wysocka, J. Mol. Cell. (2007)
- Array-based comparative genomic hybridization for the detection of DNA sequence copy number changes in Barrett's adenocarcinoma. Albrecht, B., Hausmann, M., Zitzelsberger, H., Stein, H., Siewert, J.R., Hopt, U., Langer, R., Höfler, H., Werner, M., Walch, A. J. Pathol. (2004)
- The ZNF217 gene amplified in breast cancers promotes immortalization of human mammary epithelial cells. Nonet, G.H., Stampfer, M.R., Chin, K., Gray, J.W., Collins, C.C., Yaswen, P. Cancer Res. (2001)
- Identification of Genes Directly Regulated by the Oncogene ZNF217 Using Chromatin Immunoprecipitation (ChIP)-Chip Assays. Krig, S.R., Jin, V.X., Bieda, M.C., O'geen, H., Yaswen, P., Green, R., Farnham, P.J. J. Biol. Chem. (2007)
- ZNF217 suppresses cell death associated with chemotherapy and telomere dysfunction. Huang, G., Krig, S., Kowbel, D., Xu, H., Hyun, B., Volik, S., Feuerstein, B., Mills, G.B., Stokoe, D., Yaswen, P., Collins, C. Hum. Mol. Genet. (2005)
- Frequent amplification of chromosomal region 20q12-q13 in ovarian cancer. Tanner, M.M., Grenman, S., Koul, A., Johannsson, O., Meltzer, P., Pejovic, T., Borg, A., Isola, J.J. Clin. Cancer Res. (2000)
- Differentially regulated genes as putative targets of amplifications at 20q in ovarian cancers. Watanabe, T., Imoto, I., Katahira, T., Hirasawa, A., Ishiwata, I., Emi, M., Takayama, M., Sato, A., Inazawa, J. Jpn. J. Cancer Res. (2002)